skip to main content
Refinado por: Nome da Publicação: Annals Of Oncology remover assunto: Oncology remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Final overall survival analysis for the phase II RECORD-3 study of first-line everolimus followed by sunitinib versus first-line sunitinib followed by everolimus in metastatic RCC
Material Type:
Artigo
Adicionar ao Meu Espaço

Final overall survival analysis for the phase II RECORD-3 study of first-line everolimus followed by sunitinib versus first-line sunitinib followed by everolimus in metastatic RCC

Knox, J J ; Barrios, C H ; Kim, T M ; Cosgriff, T ; Srimuninnimit, V ; Pittman, K ; Sabbatini, R ; Rha, S Y ; Flaig, T W ; Page, R D ; Beck, J T ; Cheung, F ; Yadav, S ; Patel, P ; Geoffrois, L ; Niolat, J ; Berkowitz, N ; Marker, M ; Chen, D ; Motzer, R J

Annals of oncology, 2018-11, Vol.29 (11), p.2269-2269 [Periódico revisado por pares]

England: Oxford University Press

Texto completo disponível

2
Final overall survival analysis for the phase II RECORD-3 study of first-line everolimus followed by sunitinib versus first-line sunitinib followed by everolimus in metastatic RCC
Material Type:
Artigo
Adicionar ao Meu Espaço

Final overall survival analysis for the phase II RECORD-3 study of first-line everolimus followed by sunitinib versus first-line sunitinib followed by everolimus in metastatic RCC

Knox, J.J. ; Barrios, C.H. ; Kim, T.M. ; Cosgriff, T. ; Srimuninnimit, V. ; Pittman, K. ; Sabbatini, R. ; Rha, S.Y. ; Flaig, T.W. ; Page, R.D. ; Beck, J.T. ; Cheung, F. ; Yadav, S. ; Patel, P. ; Geoffrois, L. ; Niolat, J. ; Berkowitz, N. ; Marker, M. ; Chen, D. ; Motzer, R.J.

Annals of oncology, 2017-06, Vol.28 (6), p.1339-1345 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

3
Prospective phase II trial of trabectedin in BRCA-mutated and/or BRCAness phenotype recurrent ovarian cancer patients: the MITO 15 trial
Material Type:
Artigo
Adicionar ao Meu Espaço

Prospective phase II trial of trabectedin in BRCA-mutated and/or BRCAness phenotype recurrent ovarian cancer patients: the MITO 15 trial

Lorusso, D. ; Scambia, G. ; Pignata, S. ; Sorio, R. ; Amadio, G. ; Lepori, S. ; Mosconi, A. ; Pisano, C. ; Mangili, G. ; Maltese, G. ; Sabbatini, R. ; Artioli, G. ; Gamucci, T. ; Di Napoli, M. ; Capoluongo, E. ; Ludovini, V. ; Raspagliesi, F. ; Ferrandina, G.

Annals of oncology, 2016-03, Vol.27 (3), p.487-493 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

4
Sunitinib administered on 2/1 schedule in patients with metastatic renal cell carcinoma: the RAINBOW analysis
Material Type:
Artigo
Adicionar ao Meu Espaço

Sunitinib administered on 2/1 schedule in patients with metastatic renal cell carcinoma: the RAINBOW analysis

Bracarda, S. ; Iacovelli, R. ; Boni, L. ; Rizzo, M. ; Derosa, L. ; Rossi, M. ; Galli, L. ; Procopio, G. ; Sisani, M. ; Longo, F. ; Santoni, M. ; Morelli, F. ; Di Lorenzo, G. ; Altavilla, A. ; Porta, C. ; Camerini, A. ; Escudier, B. ; Martignetti, Angelo ; Ricotta, Riccardo ; Gasparro, Donatello ; Sabbatini, Roberto ; Ceresoli, Giovanni Luca ; Mosca, Alessandra ; Santini, Daniele ; Caserta, Claudia ; Cavanna, Luigi ; Massari, Francesco ; Sava, Teodoro ; Boni, Corrado ; Verzoni, Elena ; Cartenì, Giacomo ; Hamzaj, Alketa

Annals of oncology, 2015-10, Vol.26 (10), p.2107-2113 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

5
No improvement of survival with reduced- versus high-intensity conditioning for allogeneic stem cell transplants in Ewing tumor patients
Material Type:
Artigo
Adicionar ao Meu Espaço

No improvement of survival with reduced- versus high-intensity conditioning for allogeneic stem cell transplants in Ewing tumor patients

Thiel, U. ; Wawer, A. ; Wolf, P. ; Badoglio, M. ; Santucci, A. ; Klingebiel, T. ; Basu, O. ; Borkhardt, A. ; Laws, H.-J. ; Kodera, Y. ; Yoshimi, A. ; Peters, C. ; Ladenstein, R. ; Pession, A. ; Prete, A. ; Urban, E.-C. ; Schwinger, W. ; Bordigoni, P. ; Salmon, A. ; Diaz, M.A. ; Afanasyev, B. ; Lisukov, I. ; Morozova, E. ; Toren, A. ; Bielorai, B. ; Korsakas, J. ; Fagioli, F. ; Caselli, D. ; Ehninger, G. ; Gruhn, B. ; Dirksen, U. ; Abdel-Rahman, F. ; Aglietta, M. ; Mastrodicasa, E. ; Torrent, M. ; Corradini, P. ; Demeocq, F. ; Dini, G. ; Dreger, P. ; Eyrich, M. ; Gozdzik, J. ; Guilhot, F. ; Holler, E. ; Koscielniak, E. ; Messina, C. ; Nachbaur, D. ; Sabbatini, R. ; Oldani, E. ; Ottinger, H. ; Ozsahin, H. ; Schots, R. ; Siena, S. ; Stein, J. ; Sufliarska, S. ; Unal, A. ; Ussowicz, M. ; Schneider, P. ; Woessmann, W. ; Jürgens, H. ; Bregni, M. ; Burdach, S.

Annals of oncology, 2011-07, Vol.22 (7), p.1614-1621 [Periódico revisado por pares]

Oxford: Elsevier Ltd

Texto completo disponível

6
Adjuvant systemic therapies in women with breast cancer: an audit of clinical practice in Italy
Material Type:
Artigo
Adicionar ao Meu Espaço

Adjuvant systemic therapies in women with breast cancer: an audit of clinical practice in Italy

Roila, F. ; Ballatori, E. ; Patoia, L. ; Palazzo, S. ; Veronesi, A. ; Frassoldati, A. ; Cetto, G. ; Cinieri, S. ; Goldhirsch, A.

Annals of oncology, 2003-06, Vol.14 (6), p.843-848 [Periódico revisado por pares]

Oxford: Oxford University Press

Texto completo disponível

7
Transferability to clinical practice of the results of controlled clinical trials: The case of antiemetic prophylactic treatment for cancer chemotherapy-induced nausea and vomiting
Material Type:
Artigo
Adicionar ao Meu Espaço

Transferability to clinical practice of the results of controlled clinical trials: The case of antiemetic prophylactic treatment for cancer chemotherapy-induced nausea and vomiting

Annals of oncology, 1998-07, Vol.9 (7), p.759-765 [Periódico revisado por pares]

Oxford: Oxford University Press

Texto completo disponível

8
Delayed emesis induced by moderately emetogenic chemotherapy: Do we need to treat all patients?
Material Type:
Artigo
Adicionar ao Meu Espaço

Delayed emesis induced by moderately emetogenic chemotherapy: Do we need to treat all patients?

Ballatori, E. ; Roila, F. ; Tonato, M. ; De Angelis, V. ; Riva, E. ; Barbian, P. ; Del Favero, A. ; Basurto, C. ; Ciccarese, G. ; Palladino, M. A. ; Mosconi, A. M. ; Anastasi, P. ; Picciafuoco, M. ; Campora, E. ; Chiara, S. ; Cognetti, F. ; Ferraresi, V. ; Fabi, A. ; Tonachella, R. ; Cirulli, S. ; Sabbatini, R. ; Federico, M. ; Trassoldati, A. ; Silingardi, V. ; Anna Ferrara, Arcispedale S. ; Donati, D. ; Maestri, A. ; Malacarne, P. ; Ricci, S. ; Antonuzzo, A. ; Allegrini, G. ; Conte, P. F. ; Salvati, F. ; Nunziati, F. ; Antilli, A. ; Catalano, G. ; Cascinu, S. ; Di Costanzo, F. ; Tagliaventi, M. ; Zaniboni, A. ; Meriggi, F. ; Cortesi, E. ; Ramponi, S. ; Locatelli, M. C. ; D'Antona, A. ; Santoro, A. ; Zucchinelli, P. ; Mantellim, E. ; Ferretti, G. ; Boni, C. ; Moretti, G. ; Scagliotti, G. ; Daniele, O. ; Lissoni, A. ; Tateo, S.

Annals of oncology, 1997-06, Vol.8 (6), p.561-567 [Periódico revisado por pares]

Oxford: Oxford University Press

Texto completo disponível

Buscando em bases de dados remotas. Favor aguardar.